Pharmacokinetics and metabolism of [14C]eplerenone after oral administration to humans

Drug Metabolism and Disposition

Volumn 31, Issue 11, 2003, Pages 1448-1455

  Cook, Chyung S ^a,b   Berry, Loren M ^a   Bible, Roy H ^a   Hribar, Jeremy D ^a   Hajdu, Elisabeth ^a   Liu, Norman W ^a  

^a PFIZER INC   (United States)

^b BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; EPLERENONE; CARBON; DRUG DERIVATIVE; SPIRONOLACTONE;

AREA UNDER THE CURVE; ARTICLE; CONCENTRATION RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSE; DRUG HALF LIFE; DRUG HYDROXYLATION; DRUG METABOLISM; DRUG PROTEIN BINDING; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; ADULT; CHEMISTRY; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; CARBON RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; SPIRONOLACTONE;

EID: 0142180980     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.11.1448     Document Type: Article

References (17)

1. Billecke S, Draganov D, Counsell R, Stetson P, Watson C, Hsu C, and La Du BN (2000) Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab Dispos 28:1335-1342.
2. Chanoine F, Grenot C, Sellier N, Barrett WE, Thompson RM, Fentiman AF, Nixon JR, Goyer R, and Junien JL (1987) Isolation and identification of major metabolites of tixocortol pivalate in human urine. Drug Metab Dispos 15:868-876.
3. Cook CS, Berry LM, Kim DH, Burton EG, Hribar J, and Zhang L (2002) Involvement of CYP3A in the metabolism of eplerenone in humans and dogs: differential metabolism by CYP3A4 and CYP3A5. Drug Metab Dispos 30:1344-1351.
4. Cook CS and Zhang L (2000) Absorption and disposition of a selective aldosterone receptor antagonist, eplerenone, in the dog. Pharm Res (NY) 17:1426-1431.
5. Cook CS, Zhang L, Ames GB, Fischer J, Zhang J, and Levin S (2003) Single- and repeated-dose pharmacokinetics of eplerenone, a selective aldosterone receptor blocker, in rats. Xenobiotica 33:305-321.
6. Jacobi GH and Wilson JD (1977) Formation of 5alpha-androstane-3alpha, 17beta-diol by normal and hypertrophic human prostate. J Clin Endocrinol Metab 44: 107-115.
7. Kammerer RC, Merdink JL, Jagels M, Catlin DH, and Hui KK (1990) Testing for fluoxymesterone (Halotestin) administration to man: identification of urinary metabolites by gas chromatography-mass spectrometry. J Steroid Biochem 36:659-666.
8. Liew D, Martin J, and Krum H (2003) Eplerenone. Pharmacia. Cur Opin Investig Drugs 4:316-322.
9. McMahon EG (2001) Recent studies with eplerenone, a novel selective aldosterone receptor antagonist. Curr Opin Pharmacol 1:190-196.
10. Pitt B, Remme WJ, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, and Gatlin M: Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309-1321.
11. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky A, and Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709-717.
12. Sun Y, Ramirez FJA, and Weber KT (1997) Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc Res 35:138-147.
13. Teiber JF, Draganov DI, and Du BN (2003) Lactonase and lactonizing activities of human serum paraoxygenase (PON1) and rabbit serum PON3. Biochem Pharmacol 66:887-896.
14. Wittztum JF, Draganov DI, and Du BN (2003) Lactonase and lactonizing activities of human serum para oxygenase (PON1) and rabbit serum PON3. Biochem Pharmacol 66:887-896.
15. Wittztum JL (1996) Drugs used in the treatment of hyperlipoproteinemias, in The Pharmacological Basis of Therapeutics, 9th ed. (Hardman JG and Limbird LE, eds), pp 875-897. The McGraw-Hill Companies, Inc., New York.
16. Yamazaki H and Shimada T (1997) Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9 and 3A4 in human liver microsomes. Arch Biochem Biophys 346:161-169.
17. Zhang JY, Fast DM, and Breau AP (2003) Development and validation of a liquid chromatography-tandem mass spectrometric assay for eplerenone and its hydrolyzed metabolite in human plasma. J Chromatogr B 787:333-344.